Mette Kirstine Agger's Net Worth
$24.4 Million
Who is Mette Kirstine Agger?
Mette Kirstine Agger has an estimated net worth of $24.4 Million. This is based on reported shares across multiple companies, which include Trevi Therapeutics, Inc., scPharmaceuticals Inc., IMARA Inc., and Lexeo Therapeutics, Inc..
SEC CIK
Mette Kirstine Agger's CIK is 0001722234
Past Insider Trading and Trends
2019 was Mette Kirstine Agger's most active year for acquiring shares with 4 total transactions. Mette Kirstine Agger's most active month to acquire stocks was the month of May. 2020 was Mette Kirstine Agger's most active year for disposing of shares, totalling 3 transactions. Mette Kirstine Agger's most active month to dispose stocks was the month of February. 2017 saw Mette Kirstine Agger paying a total of $9,166,668.00 for 3,183,986 shares, this is the most they've acquired in one year. In 2017 Mette Kirstine Agger cashed out on 18,160,328 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Trevi Therapeutics, Inc. (TRVI) Snapshot price: $1.47
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.15M |
$10.00 |
—
| 1.15M |
May 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
scPharmaceuticals Inc. (SCPH) Snapshot price: $5.21
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4/A
| +25.89% | 654.76K |
$14.00 | $9,166,668.00 | 3.18M |
Nov 21
| |||
Form 4
|
∞
| 2.53M |
—
|
—
| 2.53M |
Nov 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
IMARA Inc. (ELVN) Snapshot price: $15.35
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.43M |
$16.00 |
—
| 1.43M |
Mar 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Lexeo Therapeutics, Inc. (LXEO) Snapshot price: $17
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||